Bioorganic and Medicinal Chemistry Letters p. 2715 - 2718 (1998)
Update date:2022-08-30
Topics:
Yuan, Jun
Chen, Xi
Brodbeck, Robbin
Primus, Renee
Braun, Julia
Wasley, Jan W. F.
Thurkauf, Andrew
N-(4-[4-{2, 3-dichlorophenyl}-1-piperazinyl]butyl(-3- fluorenylcarboxamide and N-(4-(4-{2,3-dichlorophenyl}-1-piperazinyl]butyl)- 2-biphenylenylcarboxamide were prepared in several steps from 2,3- dichloroaniline. These compounds were identified as highly selective dopamine D3 receptor antagonists.
View MoreQingdao Pana-Life Biochem Co.,Ltd.
Contact:86-532-87683902
Address:No.967 Dalao Road, Licang Zone, Qingdao City,Shandong, China 266021
Chengdu Gelipu Biotechnology Co., Ltd.
website:http://www.glp-china.com
Contact:86-28-82610909
Address:chegndu
Suzhou SuKaiLu Chemical Technology Co., Ltd.
Contact:+86-512-62766020
Address:Floor 4, Building 1, Xinyi Pharmaceutical Valley Wisdom Industrial Park, 415 Changyang Street, Suzhou Industrial Park, Jiangsu Province
Yueyang Hudex Pharmaceuticals Ltd.
Contact:0730-8748800
Address:Wujiang Bridge,Yueyang Economy & Technology Development Zone
Contact:+86-518-81061113
Address:No. 8 Lingzhou Road, Lianyungang, Jiangsu, China
Doi:10.1021/ml100291n
(2011)Doi:10.1016/j.bmc.2018.04.009
(2018)Doi:10.1021/i560121a023
(1943)Doi:10.1021/ja102299b
(2010)Doi:10.1002/adsc.201800102
(2018)Doi:10.1007/s11172-018-2037-3
(2018)